Pluvicto | VA Phoenix Healthcare System

Award Notice Posted

Solicitation number
36C262-26-AP-0681
Agency
Awarded
to Novartis Pharmaceuticals Corporation
Set-aside
No set-aside

Opportunity facts

Contract number
36F79720D0180-36C26226F0048 Federal contract award
Place of performance
Phoenix, Arizona 85012, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs Veterans Health Administration, Veterans Integrated Service Network 22, awarded contract 36F79720D0180 to Novartis Pharmaceuticals Corporation on January 2, 2026, for the provision of Pluvicto at the VA Phoenix Healthcare System. The contract was awarded at a value of $4,984,371.00 and represents a non-competitive procurement with no set-aside provisions. Pluvicto is a pharmaceutical therapeutic agent, and this award enables the VA facility to procure this specialized medication to support veteran patient care and treatment needs.

Notice text

Awarded contract 36F79720D0180 to Novartis Pharmaceuticals Corporation for 4984371.00 on 2026-01-02.

Notice history

Notice Type Posted
This notice Award Award Notice
LSJ | Pluvicto | VA Phoenix Healthcare System Limited / Sole Source Justification
6505--PLUVICTO | LUTETIUM LU 177 VIPIVOTIDE TETRA 27mCi/ML VA Phoenix Healthcare System Latest special notice Special Notice

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity